MAP1LC3B and influenza: Both our work and the other group’s study showed that the antigen design by fusing autophagy-associated protein LC3b effectively elicited a robust immune response against influenza, Mycobacterium tuberculosis (Mtb), and simian immunodeficiency virus (SIV) infections [34,35].